Prudential Financial
DCPH

Prudential Financial’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Prudential Financial’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,416
Closed -$204K – 2490
2020
Q2 		$204K Buy
+3,416
New +$183K ﹤0.01% 2258
2020
Q1 		– Sell
-5,155
Closed -$321K – 2465
2019
Q4 		$321K Buy
+5,155
New +$245K ﹤0.01% 2185

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Prudential Financial's DCPH Position: Q3 2020 in Review

Prudential Financial sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q3 2020, closing a stake of 3,416 shares — an estimated $204K sold.

Prudential Financial first reported a position in DCPH in Q4 2019 and held it in 2 quarters. The position peaked at $321K in Q4 2019. 161 funds tracked by Wall St. Rank hold DCPH as of Q3 2020.

  • Prudential Financial reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Prudential Financial sold 3,416 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $204K.
  • Prudential Financial first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Prudential Financial's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $321K in Q4 2019.
  • 161 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Prudential Financial's 13F filing for Q3 2020, filed 16 Nov 2020.